Dr. Vicaut received consulting fees (less than $10,000 each) from Servier and Pfizer.
Hypomagnesemia associated with chondrocalcinosis: A cross-sectional study
Article first published online: 29 NOV 2007
Copyright © 2007 by the American College of Rheumatology
Arthritis Care & Research
Volume 57, Issue 8, pages 1496–1501, 15 December 2007
How to Cite
Richette, P., Ayoub, G., Lahalle, S., Vicaut, E., Badran, A.-M., Joly, F., Messing, B. and Bardin, T. (2007), Hypomagnesemia associated with chondrocalcinosis: A cross-sectional study. Arthritis & Rheumatism, 57: 1496–1501. doi: 10.1002/art.23106
- Issue published online: 29 NOV 2007
- Article first published online: 29 NOV 2007
- Manuscript Accepted: 16 MAY 2007
- Manuscript Received: 20 NOV 2006
- Association Rhumatisme et Travail (Hôpital Lariboisière, Centre Viggo Petersen, Paris)
- Calcium pyrophosphate dihydrate crystals
To determine an association between magnesium (Mg) depletion and chondrocalcinosis, which has been reported but not investigated in a cross-sectional study.
Prevalence of chondrocalcinosis was investigated in 144 individuals: 72 patients receiving home parenteral nutrition (HPN) compared with 72 age- and sex-matched controls. Presence of chondrocalcinosis was assessed by knee radiographs. Blood serum and globular Mg levels and 24-hour urinary Mg content were compared.
Mean ± SD age for both patients and controls was 51 ± 17 years, and 51% in both groups were women. Mean duration of HPN was 6.4 years. Prevalence of chondrocalcinosis was markedly higher in patients receiving HPN than controls (16.6% versus 2.7%; P = 0.006, odds ratio [OR] 7.0, 95% confidence interval [95% CI] 1.45–66.1). Mean ± SD serum and globular Mg levels were significantly lower in patients than controls (serum: 0.75 ± 0.09 mmoles/liter versus 0.81 ± 0.08 mmoles/liter, P = 0.0006; globular Mg: 1.8 ± 0.31 mmoles/liter versus 2.0 ± 0.35 mmoles/liter, P = 0.0003). Twenty-four-hour urinary Mg level was lower in patients than controls (mean ± SD 3.85 ± 1.50 mmoles versus 5.37 ± 3.71 mmoles; P = 0.001). Prevalence of chondrocalcinosis was significantly higher in patients with a low serum Mg level (OR 13.5, 95% CI 2.76–127.3, P < 0.0001), with a similarly high but not significant occurrence of chondrocalcinosis in patients with a low globular Mg level (OR 4.09, 95% CI 0.603–20.26, P = 0.08) and in patients with a low 24-hour urinary Mg level (OR 3.9, 95% CI 0.77–16.34, P = 0.05).
Long-lasting Mg depletion is strongly associated with chondrocalcinosis.